Chronisch-entzündliche Darmerkrankungen: Diagnostik und Therapie in der Praxis

Abstract

Significant increases in Crohn’s disease incidence have been noticed in recent decades. Therefore it gets more important to increase practical knowledge, present therapy innovations and draw attention to the need for vaccinations of immunosuppressed IBD patients as well as useful supportive therapy options.

Eine deutliche Inzidenzsteigerung in den letzten Jahrzehnten an chronisch-entzündlichen Darmerkrankungen (CED) Morbus Crohn und Colitis ulcerosa fordert besonders den haus- und fachärztlichen Bereich. Dieser Beitrag teilt praxisrelevantes Wissen, gibt Aussicht auf Neuerungen und weist auf erforderliche Impfungen immunsupprimierter CED-Patienten und Supportivtherapien hin.

Schlüsselwörter

Morbus Crohn - Colitis ulcerosa - Azathioprin - Impfung - Eisenmangel

Key words

Crohn’s disease - ulcerative colitis - azathioprine - vaccination - iron deficiency

• Literatur

• 1 Fumery M, Singh S, Dulai PS. et al. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol 2018; 16 (03) 343-356 . doi:10.1016/j.cgh.2017.06.016
• 2 Lee DW, Koo JS, Choe JW. et al. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol 2017; 23: 6474-6481 . doi:10.3748/wjg.v23.i35.6474
• 3 Preiß JC, Bokemeyer B, Buhr HJ. et al. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ 2014. Z Gastroenterol 2014; 52 (12) 1431-1484 . doi:10.1055/s-0034-1385199
• 4 Burri E, Beglinger C. The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Rev Gastroenterol Hepatol 2014; 8: 197-210 . doi:10.1586/17474124.2014.869476
• 5 Falt P, Šmajstrla V, Fojtík P. et al. Carbon dioxide insufflation during colonoscopy in inflammatory bowel disease patients: a double-blind, randomized, single-center trial. Eur J Gastroenterol Hepatol 2017; 29: 355-359 . doi:10.1097/MEG.0000000000000791
• 6 Farnbacher M, Hohn H, Philipper M. Positionspapier Kapselendoskopie des bng. Zeitschrift für Gastroenterologie 2014; 52: 1-4
• 7 Kucharzik T, Wittig BM, Helwig U. et al. Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity. Clin Gastroenterol Hepatol 2017; 15 (04) 535-542 . doi:10.1016/j.cgh.2016.10.040
• 8 Wenger S, Nikolaus S, Howaldt S. et al. Predictors for subsequent need for immunosuppressive therapy in early Crohn’s disease. J Crohns Colitis 2012; 6: 21-28 . doi:10.1016/j.crohns.2011.06.006
• 9 Caplan A, Fett N, Rosenbach M. et al. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects. J Am Acad Dermatol 2017; 76: 11-16 . doi:10.1016/j.jaad.2016.02.1239
• 10 Teich N, Mohl W, Bokemeyer B. et al. Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity. J Crohns Colitis 2016; 10: 61-68 . doi:10.1093/ecco-jcc/jjv188
• 11 Coenen MJH, de Jong DJ, van Marrewijk CJ. et al. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease. Gastroenterology 2015; 149: 907-917 . doi:10.1053/j.gastro.2015.06.002
• 12 Pouillon L, Bossuyt P, Peyrin-Biroulet L. Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease. Expert Opin Biol Ther 2016; 16: 1277-1290 . doi:10.1080/14712598.2016.1203897
• 13 Teich N, Klugmann T, Tiedemann A. et al. Vaccination coverage in immunosuppressed patients: results of a regional health services research study. Dtsch Arztebl Int 2011; 108: 105-111 . doi:10.3238/arztebl.2011.0105
• 14 Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut. Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010; 53: 357-388 . doi:10.1007/s00103-010-1028-9
• 15 Rosenfeld G, Bressler B. The truth about cigarette smoking and the risk of inflammatory bowel disease. Am J Gastroenterol 2012; 107: 1407-1408 . doi:10.1038/ajg.2012.190
• 16 Cosnes J, Beaugerie L, Carbonnel F. et al. Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology 2001; 120: 1093-1099
• 17 Martin J, Radeke HH, Dignass A. et al. Current evaluation and management of anemia in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2017; 11: 19-32
• 18 Maconi G, Gridavilla D, Viganò C. et al. Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission. Int J Colorectal Dis 2014; 29: 1285-1290 . doi:10.1007/s00384-014-1935-6